The Experiences of Patients with Diabetes and Strategies for Their Management During the COVID-19 Pandemic: A Qualitative Study

Anita Joeliantina; Irfany Nurul  Hamid; Endang  Sulistyowati

doi:10.35882/ijahst.v3i1.214

Authors

Anita Joeliantina Department of Nursing, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia https://orcid.org/0000-0002-0943-1769
Irfany Nurul Hamid Departement of Nursing, Politeknik Kesehatan Kemenkes Surabaya, Surabaya, Indonesia
Endang Sulistyowati Departement of Nursing, Politeknik Kesehatan Kemenkes Surabaya, Surabaya, Indonesia

DOI:

https://doi.org/10.35882/ijahst.v3i1.214

Keywords:

Anita Joeliantina, Irfany Nurul Hamid, Endang Sulistyowati

Abstract

Self-care is a key point for patients with Diabetes Mellitus (DM) to maintain normal blood sugar levels. During the COVID-19 Pandemic, patients with DM experienced limitations in carrying out self-care. The study explores in-depth the experiences of patients with DM in carrying out self-care during the pandemic of COVID-19. This type of research was qualitative research with a phenomenological approach. The number of participants in the phenomenological study was patients with DM at the Keputih Surabaya Health Center with ten people. The determination of participants is determined using the purposive sampling technique. The collecting data through in-depth interview techniques online and offline. Data analysis used the Van Manen method. There are five themes related to the self-care behavior of patients with DM during the COVID-19 pandemic in this study, namely: poor diabetic diet, absence of physical activity, impaired monitoring of blood glucose levels, change of medication pattern, and absence of foot care. DM patient's self-care behavior obtained is a decrease in diet, physical activity, monitoring blood glucose levels, and foot care. This decrease was caused by various conditions that occurred during the pandemic. In treatment behavior, it was found that there was the use of herbs as a companion to medical treatment. Furthermore, researchers need to carry out further research on strategies for implementing appropriate self-care in patients with DM during a pandemic, especially the use of herbs as a complement to treatment.

Downloads

Download data is not yet available.

References

A. Susilo et al., “Coronavirus Disease 2019: Tinjauan Literatur Terkini (Current Literature Review),” J. Penyakit Dalam Indones. (Journal Indones. Intern. Med., 2020, doi: 10.7454/jpdi.v7i1.415.

S. A. Soelistijo et al., Konsensus Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2015 (Consensus on Control and Prevention of Type 2 Diabetes Mellitus in Indonesia 2015). 2015.

J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Res. Clin. Pract., 2010, doi: 10.1016/j.diabres.2009.10.007.

Kementerian Kesehatan RI., “Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020,” Pusat Data dan Informasi Kementerian Kesehatan RI. pp. 1–10, 2020, [Online]. Available: https://pusdatin.kemkes.go.id/resources/download/pusdatin/infodatin/Infodatin-2020-Diabetes-Melitus.pdf.

Kementerian Kesehatan RI (Ministry of Health of the Republic of Indonesia), “Peta Sebaran Covid-19 di Indonesia.” 2020, [Online]. Available: https://covid19.go.id/peta-sebaran.

T. M. Barber, “COVID-19 and diabetes mellitus: implications for prognosis and clinical management,” Expert Rev. Endocrinol. Metab., vol. 15, no. 4, pp. 227–236, 2020, doi: 10.1080/17446651.2020.1774360.

A. Hussain, B. Bhowmik, and N. C. do Vale Moreira, “COVID-19 and diabetes: Knowledge in progress,” Diabetes Research and Clinical Practice. 2020, doi: 10.1016/j.diabres.2020.108142.

I. A. Kshanti, M. Epriliawati, M. I. Mokoagow, J. Nasarudin, and N. Magfira, “The Impact of COVID-19 Lockdown on Diabetes Complication and Diabetes Management in People With Diabetes in Indonesia,” J. Prim. Care Community Heal., vol. 12, 2021, doi: 10.1177/21501327211044888.

Media Info BPJS Kesehatan (Health BPJS Information Media), Implementasi PROLANIS di Masa Pandemi COVID-19 (Implementation of PROLANIS during the COVID-19 Pandemic), 100th ed. BPJS KESEHATAN.

D. F. Polit and C. T. Beck, Essentials of nursing research : appraising evidence for nursing practice, 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2010.

H. Utli and B. Vural Doğru, “The effect of the COVID-19 pandemic on self-management in patients with type 2 diabetics,” Prim. Care Diabetes, vol. 15, no. 5, pp. 799–805, 2021, doi: 10.1016/j.pcd.2021.07.009.

C. Knott-torcal and D. C. Matilla-escalante, “COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus,” Nutrients, vol. 12, no. 2327, pp. 1–16, 2020, doi: http://dx.doi.org/10.3390/nu12082327.

M. Masroor, A. Beg, K. Dev, M. A. Alsahli, A. H. Rahmani, and Y. Goyal, “Assessment and Management of Diabetic Patients During the COVID-19 Pandemic,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. I4, pp. 3131–3146, 2021.

M. Grabia et al., “nutrients The Nutritional and Health E ff ects of the COVID-19 Pandemic on Patients with Diabetes Mellitus,” Nutrients, no. June, pp. 1–15, 2020, doi: http://dx.doi.org/10.3390/nu12103013.

B. A. Binhardi et al., “Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid,” Diabetol. Metab. Syndr., vol. 13, no. 1, pp. 1–11, 2021, doi: 10.1186/s13098-021-00706-8.

S. Balducci and E. M. Coccia, “Sedentariness and physical activity in type 2 diabetes during the COVID-19 pandemic,” Diabetes. Metab. Res. Rev., vol. 37, no. 2, pp. 14–15, 2021, doi: 10.1002/dmrr.3378.

G. Tornese, V. Ceconi, L. Monasta, C. Carletti, E. Faleschini, and E. Barbi, “Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity,” Diabetes Technol. Ther., vol. 22, no. 6, pp. 462–467, 2020, doi: 10.1089/dia.2020.0169.

C. Shi, H. Zhu, J. Liu, J. Zhou, and W. Tang, “Barriers to self-management of type 2 diabetes during covid-19 medical isolation: A qualitative study,” Diabetes, Metab. Syndr. Obes. Targets Ther., vol. 13, pp. 3713–3725, 2020, doi: 10.2147/DMSO.S268481.

A. M. Angelidi, M. J. Belanger, and C. S. Mantzoros, “Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next,” Metabolism., vol. 107, p. 154245, 2020, doi: 10.1016/j.metabol.2020.154245.

J. Kang, Y. Chen, Y. Zhao, and C. Zhang, “Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic,” Prim. Care Diabetes, vol. 15, no. 3, pp. 417–423, 2021, doi: 10.1016/j.pcd.2020.12.004.

I. A. M. Kshanti et al., Pedoman Pemantauan Glukosa Darah Mandiri (Independent Blood Glucose Monitoring Guidelines). 2019.

L. . Berard, R. Siemens, and V. Woo, “2018 Clinical Practice Guidelines - Monitoring Glycemic Control,” Can. J. Diabetes, vol. 42, pp. S48–S53, 2018.

Indonesian Society of Endocrinology, “Pernyataan Resmi dan Rekomendasi Penanganan Diabetes Mellitus di era Pandemi COVID-19 (Official Statements and Recommendations for Handling Diabetes Mellitus in the Era of the COVID-19 Pandemic),” The Indonesian Society of Endocrinology. pp. 1–5, 2020.

A. Tiwari et al., “Impact of lockdown on self-care management among patients with type 2 Diabetes Mellitus residing in Lucknow city, India – A cross-sectional study,” Clin. Epidemiol. Glob. Heal., vol. 10, no. February, pp. 0–5, 2021, doi: 10.1016/j.cegh.2021.100703.

A. Joeliantina, H. N. Anugrahini, and J. Proboningsih, “The health beliefs of patient with type 2 diabetes mellitus who use herbs as a complement to self-care,” Int. J. Public Heal. Sci., vol. 10, no. 2, pp. 265–271, 2021, doi: 10.11591/ijphs.v10i2.20729.

J. Proboningsih, A. Joeliantina, A. Novitasari, and D. Purnamawati, “Complementary treatment to reduce blood sugar levels of type 2 diabetes mellitus patients,” Int. J. Public Heal. Sci., vol. 9, no. 3, pp. 267–271, 2020, doi: 10.11591/ijphs.v9i3.20434.

F. O. Kamel, R. M. Magadmi, M. M. Hagras, B. Magadmi, and R. A. AlAhmad, “Knowledge, attitude, and beliefs toward traditional herbal medicine use among diabetics in Jeddah Saudi Arabia,” Complement. Ther. Clin. Pract., vol. 29, no. 2017, pp. 207–212, 2017, doi: 10.1016/j.ctcp.2017.10.007.

H. Radwan et al., “Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates,” BMC Complement. Med. Ther., vol. 20, no. 216, pp. 1–12, 2020, doi: 10.1186/s12906-020-03011-5.

R. Naemi, N. Chockalingam, J. K. Lutale, and Z. G. Abbas, “Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania,” BMJ open diabetes Res. care, vol. 8, no. 1, pp. 1–13, 2020, doi: 10.1136/bmjdrc-2019-001122.

S. Indrayana, S. E. Guo, C. L. Lin, and S. Y. Fang, “Illness Perception as a Predictor of Foot Care Behavior Among People With Type 2 Diabetes Mellitus in Indonesia,” J. Transcult. Nurs., vol. 30, no. 1, pp. 17–25, 2019, doi: 10.1177/1043659618772347.

S. C. Mishra, K. C. Chhatbar, A. Kashikar, and A. Mehndiratta, “Diabetic foot: Clinical Update (Open Acces),” Bmj, vol. 359, no. Supp1, pp. 1–7, 2017, doi: 10.1136/bmj.j5064.

M. Thomaz et al., “COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis,” diabetes Res. Clin. Pract., vol. 171, 2021, doi: 10.1016/j.diabres.2020.108587.

M. Apicella, M. C. Campopiano, M. Mantuano, L. Mazoni, A. Coppelli, and S. Del Prato, “Review COVID-19 in people with diabetes : understanding the reasons for worse outcomes,” LANCET Diabetes Endocrinol., vol. 8, no. 9, pp. 782–792, 2020, doi: 10.1016/S2213-8587(20)30238-2.

A. Joeliantina, M. Agil, M. B. Qomaruddin, Kusnanto, and O. Soedirham, “Family support for diabetes self-care behavior in T2DM patients who use herbs as a complementary treatment,” Medico-Legal Updat., vol. 19, no. 1, pp. 238–243, 2019, doi: 10.5958/0974-1283.2019.00048.3.